ID   ACHA7_RAT               Reviewed;         502 AA.
AC   Q05941; Q53YK2;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   27-MAR-2024, entry version 179.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-7;
DE   Flags: Precursor;
GN   Name=Chrna7; Synonyms=Acra7;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7678857; DOI=10.1523/jneurosci.13-02-00596.1993;
RA   Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W.;
RT   "Molecular cloning, functional properties, and distribution of rat brain
RT   alpha 7: a nicotinic cation channel highly permeable to calcium.";
RL   J. Neurosci. 13:596-604(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Boulter J.;
RL   Submitted (APR-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   SEQUENCE REVISION TO 363.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Hartley M.;
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Groot-Kormelink P.J.;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   INTERACTION WITH RIC3, MUTAGENESIS OF LEU-433; LYS-435; VAL-440; ASN-445;
RP   ARG-446; PHE-447 AND ARG-448, AND SUBCELLULAR LOCATION.
RX   PubMed=15927954; DOI=10.1074/jbc.m503746200;
RA   Castillo M., Mulet J., Gutierrez L.M., Ortiz J.A., Castelan F., Gerber S.,
RA   Sala S., Sala F., Criado M.;
RT   "Dual role of the RIC-3 protein in trafficking of serotonin and nicotinic
RT   acetylcholine receptors.";
RL   J. Biol. Chem. 280:27062-27068(2005).
RN   [6]
RP   INTERACTION WITH RIC3.
RX   PubMed=16120769; DOI=10.1124/mol.105.017459;
RA   Lansdell S.J., Gee V.J., Harkness P.C., Doward A.I., Baker E.R., Gibb A.J.,
RA   Millar N.S.;
RT   "RIC-3 enhances functional expression of multiple nicotinic acetylcholine
RT   receptor subtypes in mammalian cells.";
RL   Mol. Pharmacol. 68:1431-1438(2005).
RN   [7]
RP   MUTAGENESIS OF SER-81 AND LEU-141, AND SUBUNIT.
RX   PubMed=25740413; DOI=10.1124/mol.114.096511;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Molecular interaction of alpha-conotoxin RgIA with the rat alpha9alpha10
RT   nicotinic acetylcholine receptor.";
RL   Mol. Pharmacol. 87:855-864(2015).
RN   [8]
RP   ERRATUM OF PUBMED:25740413.
RX   PubMed=27559150; DOI=10.1124/mol.114.096511err;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Corrections to 'Molecular interaction of alpha-conotoxin RgIA with the rat
RT   alpha9alpha10 nicotinic acetylcholine receptor'.";
RL   Mol. Pharmacol. 90:415-417(2016).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and leads to
CC       opening of an ion-conducting channel across the plasma membrane. The
CC       channel is blocked by alpha-bungarotoxin.
CC   -!- SUBUNIT: Homopentamer (By similarity). Interacts with RIC3; which is
CC       required for proper folding and assembly (PubMed:15927954,
CC       PubMed:16120769). Interacts with LYPD6 (By similarity). Interacts with
CC       the alpha-conotoxin RgIA (PubMed:25740413). Interacts with alpha-
CC       conotoxins ImI and ImII (By similarity). Interacts with CANX (By
CC       similarity). {ECO:0000250|UniProtKB:P36544,
CC       ECO:0000250|UniProtKB:P54131, ECO:0000269|PubMed:15927954,
CC       ECO:0000269|PubMed:16120769, ECO:0000269|PubMed:25740413}.
CC   -!- INTERACTION:
CC       Q05941; PRO_0000000092 [P05067]: APP; Xeno; NbExp=3; IntAct=EBI-79422, EBI-821758;
CC       Q05941; Q7Z2K8: GPRIN1; Xeno; NbExp=6; IntAct=EBI-79422, EBI-11152848;
CC       Q05941; P60615; Xeno; NbExp=4; IntAct=EBI-79422, EBI-7516391;
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane; Multi-pass membrane
CC       protein {ECO:0000255}. Cell membrane {ECO:0000269|PubMed:15927954};
CC       Multi-pass membrane protein {ECO:0000255}. Note=RIC3 promotes its
CC       trafficking to the cell membrane (PubMed:15927954). TMEM35A/NACHO
CC       promotes its trafficking to the cell membrane (By similarity).
CC       {ECO:0000250|UniProtKB:P49582, ECO:0000269|PubMed:15927954}.
CC   -!- PTM: Glycosylations at Asn-46, Asn-90 and Asn-133 are essential for
CC       TMEM35A/NACHO-mediated proper subunit assembly and trafficking to the
CC       cell membrane. {ECO:0000250|UniProtKB:P49582}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-7/CHRNA7 sub-
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S53987; AAB25224.2; -; mRNA.
DR   EMBL; L31619; AAC33136.1; -; mRNA.
DR   EMBL; AY574256; AAS90352.1; -; mRNA.
DR   PIR; T01378; T01378.
DR   RefSeq; NP_036964.3; NM_012832.3.
DR   AlphaFoldDB; Q05941; -.
DR   SMR; Q05941; -.
DR   ComplexPortal; CPX-233; Neuronal nicotinic acetylcholine receptor complex, alpha7.
DR   ComplexPortal; CPX-237; Neuronal nicotinic acetylcholine receptor complex, alpha7-beta2.
DR   IntAct; Q05941; 5.
DR   MINT; Q05941; -.
DR   STRING; 10116.ENSRNOP00000045255; -.
DR   BindingDB; Q05941; -.
DR   ChEMBL; CHEMBL4980; -.
DR   DrugCentral; Q05941; -.
DR   GuidetoPHARMACOLOGY; 468; -.
DR   GlyCosmos; Q05941; 3 sites, No reported glycans.
DR   GlyGen; Q05941; 3 sites.
DR   iPTMnet; Q05941; -.
DR   PhosphoSitePlus; Q05941; -.
DR   SwissPalm; Q05941; -.
DR   PaxDb; 10116-ENSRNOP00000045255; -.
DR   Ensembl; ENSRNOT00000082487.2; ENSRNOP00000073551.2; ENSRNOG00000010853.8.
DR   Ensembl; ENSRNOT00055025208; ENSRNOP00055020610; ENSRNOG00055014663.
DR   Ensembl; ENSRNOT00060031572; ENSRNOP00060025640; ENSRNOG00060018361.
DR   Ensembl; ENSRNOT00065041441; ENSRNOP00065033852; ENSRNOG00065024127.
DR   GeneID; 25302; -.
DR   KEGG; rno:25302; -.
DR   UCSC; RGD:2348; rat.
DR   AGR; RGD:2348; -.
DR   CTD; 1139; -.
DR   RGD; 2348; Chrna7.
DR   eggNOG; KOG3646; Eukaryota.
DR   GeneTree; ENSGT00940000154617; -.
DR   InParanoid; Q05941; -.
DR   OrthoDB; 5489962at2759; -.
DR   PhylomeDB; Q05941; -.
DR   Reactome; R-RNO-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   PRO; PR:Q05941; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:ARUK-UCL.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0032279; C:asymmetric synapse; IDA:RGD.
DR   GO; GO:0030673; C:axolemma; ISO:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0098981; C:cholinergic synapse; IDA:SynGO.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0098690; C:glycinergic synapse; IDA:SynGO.
DR   GO; GO:0030426; C:growth cone; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0044853; C:plasma membrane raft; IDA:ARUK-UCL.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:RGD.
DR   GO; GO:0098897; C:spine apparatus membrane; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0042166; F:acetylcholine binding; IDA:RGD.
DR   GO; GO:0015464; F:acetylcholine receptor activity; ISO:RGD.
DR   GO; GO:0022848; F:acetylcholine-gated monoatomic cation-selective channel activity; IDA:MGI.
DR   GO; GO:0008179; F:adenylate cyclase binding; IPI:RGD.
DR   GO; GO:0001540; F:amyloid-beta binding; ISO:RGD.
DR   GO; GO:0051117; F:ATPase binding; IDA:RGD.
DR   GO; GO:0017081; F:chloride channel regulator activity; ISO:RGD.
DR   GO; GO:0005216; F:monoatomic ion channel activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; IDA:RGD.
DR   GO; GO:0015643; F:toxic substance binding; ISO:RGD.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; IDA:ARUK-UCL.
DR   GO; GO:0008306; P:associative learning; ISO:RGD.
DR   GO; GO:0042113; P:B cell activation; ISO:RGD.
DR   GO; GO:0048149; P:behavioral response to ethanol; ISO:RGD.
DR   GO; GO:0035095; P:behavioral response to nicotine; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; IMP:MGI.
DR   GO; GO:0050890; P:cognition; ISO:RGD.
DR   GO; GO:0140059; P:dendrite arborization; ISO:RGD.
DR   GO; GO:0097061; P:dendritic spine organization; ISO:RGD.
DR   GO; GO:0042416; P:dopamine biosynthetic process; IEP:RGD.
DR   GO; GO:0006897; P:endocytosis; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0030317; P:flagellated sperm motility; ISO:RGD.
DR   GO; GO:0060112; P:generation of ovulation cycle rhythm; ISO:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; IMP:RGD.
DR   GO; GO:0007613; P:memory; IDA:ARUK-UCL.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0098815; P:modulation of excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; IDA:RGD.
DR   GO; GO:0006811; P:monoatomic ion transport; ISO:RGD.
DR   GO; GO:1902430; P:negative regulation of amyloid-beta formation; ISO:RGD.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:RGD.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0032691; P:negative regulation of interleukin-1 beta production; ISO:RGD.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; IMP:RGD.
DR   GO; GO:0042698; P:ovulation cycle; ISO:RGD.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; ISO:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:ARUK-UCL.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:RGD.
DR   GO; GO:0001988; P:positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure; ISO:RGD.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0051247; P:positive regulation of protein metabolic process; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:1905906; P:regulation of amyloid fibril formation; ISO:RGD.
DR   GO; GO:1902991; P:regulation of amyloid precursor protein catabolic process; ISO:RGD.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:MGI.
DR   GO; GO:0014061; P:regulation of norepinephrine secretion; ISO:RGD.
DR   GO; GO:2001023; P:regulation of response to drug; IDA:RGD.
DR   GO; GO:0051823; P:regulation of synapse structural plasticity; ISO:RGD.
DR   GO; GO:0032225; P:regulation of synaptic transmission, dopaminergic; ISO:RGD.
DR   GO; GO:1905144; P:response to acetylcholine; IDA:ARUK-UCL.
DR   GO; GO:1904645; P:response to amyloid-beta; ISO:RGD.
DR   GO; GO:0046681; P:response to carbamate; IEP:RGD.
DR   GO; GO:0009409; P:response to cold; ISO:RGD.
DR   GO; GO:0045471; P:response to ethanol; ISO:RGD.
DR   GO; GO:0032094; P:response to food; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0035094; P:response to nicotine; IDA:RGD.
DR   GO; GO:0050893; P:sensory processing; IDA:ARUK-UCL.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IMP:RGD.
DR   GO; GO:0042110; P:T cell activation; ISO:RGD.
DR   CDD; cd19020; LGIC_ECD_nAChR_A7; 1.
DR   CDD; cd19051; LGIC_TM_cation; 1.
DR   Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1.
DR   Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 2.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   NCBIfam; TIGR00860; LIC; 1.
DR   PANTHER; PTHR18945:SF907; CHRNA7-FAM7A FUSION PROTEIN-RELATED; 1.
DR   PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1.
DR   SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000250"
FT   CHAIN           23..502
FT                   /note="Neuronal acetylcholine receptor subunit alpha-7"
FT                   /id="PRO_0000000369"
FT   TOPO_DOM        23..230
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        231..255
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        262..280
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        296..317
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        318..469
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        470..490
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          260..267
FT                   /note="Essential for TMEM35A/NACHO-mediated proper subunit
FT                   assembly and trafficking to cell membrane"
FT                   /evidence="ECO:0000250|UniProtKB:P49582"
FT   CARBOHYD        46
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        90
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        133
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        150..164
FT                   /evidence="ECO:0000250"
FT   DISULFID        212..213
FT                   /note="Associated with receptor activation"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         81
FT                   /note="S->T: 10-fold more potently inhibited by the alpha-
FT                   conotoxin RgIA."
FT                   /evidence="ECO:0000269|PubMed:25740413"
FT   MUTAGEN         141
FT                   /note="L->D: No change in inhibition by the alpha-conotoxin
FT                   RgIA."
FT                   /evidence="ECO:0000269|PubMed:25740413"
FT   MUTAGEN         433
FT                   /note="L->A: Abolishes dependency on RIC3 for functional
FT                   expression."
FT                   /evidence="ECO:0000269|PubMed:15927954"
FT   MUTAGEN         435
FT                   /note="K->A: No effect on dependency on RIC3 for functional
FT                   expression."
FT                   /evidence="ECO:0000269|PubMed:15927954"
FT   MUTAGEN         440
FT                   /note="V->A: Impairs dependency on RIC3 for functional
FT                   expression."
FT                   /evidence="ECO:0000269|PubMed:15927954"
FT   MUTAGEN         445
FT                   /note="N->A: Slightly impairs dependency on RIC3 for
FT                   functional expression."
FT                   /evidence="ECO:0000269|PubMed:15927954"
FT   MUTAGEN         446
FT                   /note="R->A: Impairs dependency on RIC3 for functional
FT                   expression."
FT                   /evidence="ECO:0000269|PubMed:15927954"
FT   MUTAGEN         447
FT                   /note="F->A: Impairs dependency on RIC3 for functional
FT                   expression."
FT                   /evidence="ECO:0000269|PubMed:15927954"
FT   MUTAGEN         448
FT                   /note="R->A: Impairs dependency on RIC3 for functional
FT                   expression."
FT                   /evidence="ECO:0000269|PubMed:15927954"
FT   CONFLICT        447
FT                   /note="F -> N (in Ref. 1; AAB25224)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        469
FT                   /note="R -> P (in Ref. 1; AAB25224)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   502 AA;  56503 MW;  289A30498C7B9A58 CRC64;
     MCGGRGGIWL ALAAALLHVS LQGEFQRRLY KELVKNYNPL ERPVANDSQP LTVYFSLSLL
     QIMDVDEKNQ VLTTNIWLQM SWTDHYLQWN MSEYPGVKNV RFPDGQIWKP DILLYNSADE
     RFDATFHTNV LVNASGHCQY LPPGIFKSSC YIDVRWFPFD VQQCKLKFGS WSYGGWSLDL
     QMQEADISSY IPNGEWDLMG IPGKRNEKFY ECCKEPYPDV TYTVTMRRRT LYYGLNLLIP
     CVLISALALL VFLLPADSGE KISLGITVLL SLTVFMLLVA EIMPATSDSV PLIAQYFAST
     MIIVGLSVVV TVIVLRYHHH DPDGGKMPKW TRIILLNWCA WFLRMKRPGE DKVRPACQHK
     PRRCSLASVE LSAGAGPPTS NGNLLYIGFR GLEGMHCAPT PDSGVVCGRL ACSPTHDEHL
     MHGAHPSDGD PDLAKILEEV RYIANRFRCQ DESEVICSEW KFAACVVDRL CLMAFSVFTI
     ICTIGILMSA PNFVEAVSKD FA
//
